Rituximab Vasculitis Maintenance Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Jayne
Cambridge University Hospitals NHS Foundation Trust
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Canberra Hospital
Garran, Australian Capital Territory, Australia
- Royal Brisbane & Women'S Hospital
Herston, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- St. Joseph'S Healthcare
Hamilton, Ontario, Canada
- Mount Sinai Hospital
Toronto, Ontario, Canada
- General Faculty Hospital
Prague, Czechia
- Cork University Hospital
Cork, Ireland
- University Hospital of Parma
Parma, Italy
- Okayama University
Kita-ku, Okayama-ken, Japan
- Chiba University
Chiba, Japan
- Kitano Hospital
Kyoto, Japan
- University of Miyazaki
Miyazaki, Japan
- Kyorin University School of Medicine
Tokyo, Japan
- Teikyo University
Tokyo, Japan
- Tokyo Metropolitan Geriatric
Tokyo, Japan
- Auckland City Hospital
Grafton, Auckland, New Zealand
- North Shore Hospital
Westlake, Auckland, New Zealand
- Karolinska University Hospital
Stockholm, Sweden
- Leicester General Hospital
Leicester, Leicestershire, United Kingdom
- Queen Elizabeth Hospital
Birmingham, United Kingdom
- Brighton and Sussex University Hospitals
Brighton, United Kingdom
- Addenbrooke'S Hospital
Cambridge, United Kingdom
- Russells Hall Hospital
Dudley, United Kingdom
- Ipswich Hospital
Ipswich, United Kingdom
- Chapel Allerton Hospital
Leeds, United Kingdom
- Imperial College
London, United Kingdom
- James Cook University Hospital
Middlesbrough, United Kingdom
- Queen'S Medical Centre Campus, Nottingham University Hosp
Nottingham, United Kingdom
- University of Oxford
Oxford, United Kingdom
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Hospital for Special Surgery
New York, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2013
- Primary completion
- 22 Nov 2018
- Completion
- 21 Nov 2019
- Last update posted
- 18 Mar 2022
- Registered enrollment
- 188
- Registry id
- NCT01697267
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.